[Significant Events]

IDREAMSKY (01119) has reached a cooperation agreement with stc play in the technology and gaming fields.

ASCLETIS-B (01672): The candidate drug ASC47 for treating obesity while preserving muscle shows better weight loss effects when combined with semaglutide in preclinical models compared to semaglutide alone.

DYNASTY WINES (00828) intends to establish a joint venture with Jiu Zhong Xian to sign a joint venture cooperation agreement to produce and sell Huangjiu (Chinese Liquor) and Chen Pi Jiu in Dongtai City.

SHOUCHENG (00697) plans to sell approximately 0.607 billion shares of SHOUGANG RES for around 1.4566 billion HKD.

REGENT PACIFIC (00575): Submitted a new drug application for Senstend to the National Medical Products Administration of China.

SINO BIOPHARM (01177): The injection of Bemarituzumab combined or not combined with Anlotinib hydrochloride capsules has achieved positive results in the Phase III study for the consolidation treatment after chemotherapy for non-small cell lung cancer.

TIANJIN CAPITAL (01065) intends to acquire the Zhangguizhuang recycled water plant project Assets for 0.218 billion yuan.

[Earnings Reports Data]

SUNSHINE INS (06963): For the first 11 months, the premium income from original insurance contracts for Sunshine Life Insurance reached 77.089 billion yuan, a year-on-year increase of 12.6%.

QPL INT'L (00243) announced its interim results with a net profit of approximately 11.26 million Hong Kong dollars, turning from a loss to a profit year-on-year.

Repurchase/Shareholding

ANTA SPORTS (02020) spent about 0.209 billion Hong Kong dollars to repurchase 2.6382 million shares on December 18.

TENCENT (00700) spent 0.703 billion Hong Kong dollars to repurchase 1.73 million shares on December 18.

KUAISHOU-W (01024) spent 19.6397 million HKD to repurchase 0.43 million shares on December 18.

For more details, please refer to 智通财经网().